Virology News and Research

Latest Virology News and Research

ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN

ISA Pharmaceuticals B.V., a clinical-stage biopharmaceutical company focusing on rationally designed, fully synthetic therapeutic vaccines against cancer and persistent viral infections, today announced the initiation of a Phase I/II clinical study of its lead candidate ISA101 in HIV-positive men suffering from anal intraepithelial neoplasia.

16 Sep 2013

Research findings bring scientists one step closer to preventing HIV infections

In a long-awaited finding, a team of Chinese and US scientists has determined the high-resolution atomic structure of a cell-surface receptor that most strains of HIV use to get into human immune cells. The researchers also showed where maraviroc, an HIV drug, attaches to cells and blocks HIV’s entry.

13 Sep 2013

Pew honors creative work on coronaviruses with biomedical researcher award

Cell biologist Carolyn Machamer, Ph.D is The Pew Charitable Trusts' biomedical researcher of the month for her creative work on coronaviruses. Specifically, Machamer studies how the family of viruses uses a host cell's machinery against it.

13 Sep 2013

Study: Higher rates of acute hepatitis C virus clearance are seen in women

A study of patients infected with acute hepatitis C virus (HCV) infection found that women had higher rates of spontaneous viral clearance—undetectable levels of the virus without initiating drug therapy.

13 Sep 2013

Helper T cells important for AIDS vaccine development

A major new finding that will significantly advance efforts to create the world's first antibody-based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology.

13 Sep 2013

Researchers potentially reached milestone in vaccine treatment for genital herpes

Sexually transmitted infection researchers potentially have reached a milestone in vaccine treatment for genital herpes, according to a report to be presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in Denver, Colo., on today, Sept. 12.

13 Sep 2013

Researcher characterises influenza A viruses in gulls and ducks

Ducks and gulls are the natural hosts of influenza A virus. Ragnhild Tønnessen's PhD research project has characterised influenza A viruses in gulls and ducks in Norway. Her discoveries may lead to a better understanding of the epidemiology and host adaptation of influenza A virus.

12 Sep 2013

Wake Forest Baptist conducts $24 million project to accelerate development of new therapies

Whether it's the Ebola virus or Sarin and Ricin, a key to responding to chemical or biological attacks is having effective antidotes at the ready. To accelerate the development of new therapies, Wake Forest Baptist Medical Center's Institute for Regenerative Medicine is leading a unique $24 million federally funded project to develop a "body on a chip" that will be used to develop these countermeasures.

12 Sep 2013

New HIV/AIDS vaccine candidate appears to clear AIDS-causing virus from body

An HIV/AIDS vaccine candidate developed by researchers at Oregon Health & Science University appears to have the ability to completely clear an AIDS-causing virus from the body.

12 Sep 2013

Scientists discover that copper alloys shut down highly infectious norovirus

Scientists from the University of Southampton have discovered that copper and copper alloys rapidly destroy norovirus - the highly-infectious sickness bug.

12 Sep 2013

Researchers develop innovative system to test how virus interacts with cells in body

Researchers at The Mount Sinai Medical Center have developed an innovative system to test how a virus interacts with cells in the body — to see, for example, what happens in lung cells when a deadly respiratory virus attacks them.

12 Sep 2013

Phobias, anxiety are typical reasons why many decline to donate blood

As few as 3 percent of Americans eligible to donate blood do, and fear and anxiety are common reasons why many decline to give. U.S. hospitals are always in need of new donors; at Mayo Clinic, that need is heightened by concern about iron deficiency in frequent givers.

11 Sep 2013

Pain, itching associated with shingles may be due to virus causing "short circuit" in nerve cells

The pain and itching associated with shingles and herpes may be due to the virus causing a "short circuit" in the nerve cells that reach the skin, Princeton researchers have found.

11 Sep 2013

Research finding could lead to better solutions for cancer, anti-viral treatments

Medical scientists at the University of Alberta have made a key discovery about how the immune system kills healthy cells while attacking infections. This finding could one day lead to better solutions for cancer and anti-viral treatments.

11 Sep 2013

Interferon-alpha 2b and ribavirin treatment may be effective for MERS-CoV infection

Treatment with two common drugs reduced viral replication and lung damage when given to monkeys infected with the virus that causes Middle East Respiratory Syndrome. The condition is deadly pneumonia that has killed more than 100 people, primarily in the Middle East.

10 Sep 2013

Boehringer Ingelheim completes patient enrolment for interferon-free hepatitis C treatment

Boehringer Ingelheim today announced the completion of patient enrolment for a Phase IIa clinical trial investigating a new interferon-free, all-oral, direct-acting antiviral combination treatment for patients with genotype-1a chronic hepatitis C virus infection.

10 Sep 2013

Combination of 2 antiviral drugs improves outcome in monkey model of MERS-CoV infection

National Institutes of Health (NIH) scientists report that a combination of two licensed antiviral drugs reduces virus replication and improves clinical outcome in a recently developed monkey model of Middle East respiratory syndrome coronavirus (MERS-CoV) infection.

10 Sep 2013

Novel viral therapy to treat specific types of cancer in children

Parents do everything they can to protect their children against all of the nasty germs floating around classrooms across the country this time of year. Doctors and researchers at Nationwide Children's Hospital, however, are looking into how those same types of common viruses can actually help treat a child who is diagnosed with certain cancers.

10 Sep 2013

Scientists develop strain of MERS-CoV that can be used as vaccine against disease

Scientists have developed a strain of the Middle East respiratory syndrome coronavirus (MERS-CoV) that could be used as a vaccine against the disease, according to a study to be published in mBio-, the online open-access journal of the American Society for Microbiology.

10 Sep 2013

Emerging H7N9 virus has potential to cause a pandemic

A new study has found that a novel avian-origin H7N9 influenza A virus, which has recently emerged in humans, attaches moderately or abundantly to the epithelium of both the upper and lower respiratory tracts.

10 Sep 2013

Virology News and Research

Latest Virology News and Research

ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN

Research findings bring scientists one step closer to preventing HIV infections

Pew honors creative work on coronaviruses with biomedical researcher award

Study: Higher rates of acute hepatitis C virus clearance are seen in women

Helper T cells important for AIDS vaccine development

Researchers potentially reached milestone in vaccine treatment for genital herpes

Researcher characterises influenza A viruses in gulls and ducks

Wake Forest Baptist conducts $24 million project to accelerate development of new therapies

New HIV/AIDS vaccine candidate appears to clear AIDS-causing virus from body

Scientists discover that copper alloys shut down highly infectious norovirus

Researchers develop innovative system to test how virus interacts with cells in body

Phobias, anxiety are typical reasons why many decline to donate blood

Pain, itching associated with shingles may be due to virus causing "short circuit" in nerve cells

Research finding could lead to better solutions for cancer, anti-viral treatments

Interferon-alpha 2b and ribavirin treatment may be effective for MERS-CoV infection

Boehringer Ingelheim completes patient enrolment for interferon-free hepatitis C treatment

Combination of 2 antiviral drugs improves outcome in monkey model of MERS-CoV infection

Novel viral therapy to treat specific types of cancer in children

Scientists develop strain of MERS-CoV that can be used as vaccine against disease

Emerging H7N9 virus has potential to cause a pandemic

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics